- Home
- CRT vs PSNL Comparison
CRT vs PSNL Comparison
Compare CRT & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRT | PSNL |
|---|---|---|
| Founded | 1991 | 2011 |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.3M | 729.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | CRT | PSNL |
|---|---|---|
| Price | $9.64 | $7.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | 38.2K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 7.03% | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,648,000.00 |
| Revenue This Year | N/A | $16.94 |
| Revenue Next Year | N/A | $36.58 |
| P/E Ratio | $11.55 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.07 | $2.83 |
| 52 Week High | $13.31 | $11.50 |
Technical Indicators
Market Signals| Indicator | CRT | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 71.75 | 42.75 |
| Support Level | $9.57 | $7.37 |
| Resistance Level | $9.86 | $9.64 |
| Average True Range (ATR) | 0.21 | 0.69 |
| MACD | 0.06 | -0.06 |
| Stochastic Oscillator | 81.44 | 21.89 |
Price Performance
Historical ComparisonAbout CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.